Senior Advisor, Analytical Chemistry - Antibody-drug Conjugates

Eli Lilly Eli Lilly · Pharma · Indianapolis, IN

This role focuses on analytical chemistry for antibody-drug conjugates (ADCs) within a pharmaceutical company. It involves leading the development, qualification, and characterization of analytical methods for linker-payload intermediates, supporting regulatory submissions, and collaborating with cross-functional teams. The role requires expertise in CMC analytical development and understanding of regulatory requirements in the pharmaceutical industry.

What you'd actually do

  1. Lead analytical efforts focused on development and commercialization of the linker payload intermediate required for antibody-drug conjugates, as well as demonstrate familiarity with applicable regulatory requirements and emerging trends in the industry.
  2. Lead external and/or lead internal analytical method development and qualification of ADC linker-payload intermediate and RSM; establish specifications, characterize impurities and degradation pathways, support purge/fate studies, establish reference standard and stability studies
  3. Collaborate within project teams to deliver robust control strategies for linker payload intermediates and process impurities. Demonstrates a depth of knowledge in concepts relevant to the linker or payload, monoclonal antibody, drug substance, and drug product commercialization, including developing analytical methods, justifying specifications, authoring regulatory submissions and addressing questions from global regulatory agencies.
  4. Drive the implementation of technical solutions and analytical strategies to enable linker payload intermediate and/or conjugated drug substance/drug product process design.

Skills

Required

  • Ph.D. in analytical chemistry, organic chemistry, or a related field with 3+ years of experience in the pharmaceutical industry; OR M.S. with 8+ years OR B.S. with 12+ years of relevant industry experience.
  • CMC analytical development for linker-payloads/small molecule therapeutics or synthetic molecule
  • analytical method development and qualification
  • characterize impurities and degradation pathways
  • authoring regulatory submissions

Nice to have

  • experience authoring IND/CTA, BLA/NDA/MAA, and country-specific Response to Questions (RtQ)
  • technical guidance for analytical activities executed within the external network
  • technology transfer to CRO/CMO organizations and Lilly manufacturing sites
  • high learning agility
  • mentor and develop scientific staff
  • introduction of new methodologies for optimization of antibody-drug conjugate development and manufacturing
  • plan and manage short-term and long-term development activities
  • recommend resource allocation
  • communicate progress and propose changes in timeline, objectives, or direction
  • collaborate closely with organizations across Discovery, Development, and Manufacturing
  • Embrace diverse thoughts, backgrounds, and experiences
  • strong communication (oral, written), organizational, and leadership skills
  • actively engage in the external environment and the ability to recognize and apply external innovation

What the JD emphasized

  • Proven experience in CMC analytical development for linker-payloads/small molecule therapeutics or synthetic mole